Appointments and Medicines Consent




NEW ZEALAND GAZETTE, No. 19 — 3 MARCH 2016

the New Zealand Fire Service Commission

Paul Desmond Swain

as a member and Chair for a term commencing on 1 April 2016 and ending on 31 March 2019.

Dated at Wellington this 23rd day of February 2016.

Hon PETER DUNNE, Minister of Internal Affairs.

2016-go1127

Appointment to Northland District Health Board

Pursuant to section 28(1)(a) of the Crown Entities Act 2004, the Minister of Health has appointed

Denise Jensen

as a member of the board of the Northland District Health Board for a term of office commencing on the date of publication of this notice and ending on 4 December 2016.

Dated at Wellington this 22nd day of February 2016.

Hon Dr JONATHAN COLEMAN, Minister of Health.

2016-go1130

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Ritalin LA
Active Ingredient: Methylphenidate hydrochloride 60mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Recro Gainesville LLC, Georgia, United States of America

Dated this 25th day of February 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go1131

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Pamisol™
Active Ingredient: Pamidronic acid 2.53mg/mL equivalent to pamidronate disodium 3mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Hospira Australia Pty Limited, Melbourne, Australia

Product: Pamisol™
Active Ingredient: Pamidronic acid 5.05mg/mL equivalent to pamidronate disodium 6mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Hospira Australia Pty Limited, Melbourne, Australia

49



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 19





✨ LLM interpretation of page content

🏛️ Appointment to the New Zealand Fire Service Commission

🏛️ Governance & Central Administration
23 February 2016
Appointment, Fire Service Commission, Chair, Wellington
  • Paul Desmond Swain, Appointed member and Chair

  • Hon Peter Dunne, Minister of Internal Affairs

🏥 Appointment to Northland District Health Board

🏥 Health & Social Welfare
22 February 2016
Appointment, District Health Board, Northland
  • Denise Jensen, Appointed board member

  • Hon Dr Jonathan Coleman, Minister of Health

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
25 February 2016
Medicine, Consent, Distribution, Ritalin LA, Methylphenidate hydrochloride
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
25 February 2016
Medicine, Consent, Distribution, Pamisol, Pamidronic acid
  • Chris James, Acting Group Manager, Medsafe, Ministry of Health